The College of Oxford has launched a examine to evaluate the protection and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in kids for the primary time, it stated on Saturday.
The brand new mid-stage trial will decide whether or not the vaccine is efficient on folks between the ages of 6 and 17, in keeping with an emailed assertion from the college.
Round 300 volunteers will probably be enrolled and first inoculations are anticipated this month, Oxford stated.
The 2-dose Oxford/AstraZeneca vaccine has been hailed as a ‘vaccine for the world’ as a result of it’s cheaper and simpler to distribute than some rivals.
AstraZeneca has a goal to supply 3 billion doses this year and goals to supply over 200 million doses monthly by April.
(Aside from the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)